{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:48:52Z","timestamp":1791650932758,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A team-based approach is essential to provide cancer patients with high-quality treatment. To ensure the best possible care while reducing the workload of physicians, Ehime University Hospital has introduced three protocol-based pharmacotherapy management (PBPM) strategies in the field of chemotherapy. First, we introduced PBPM to avoid reactivation of hepatitis B virus (HBV) in patients receiving immunosuppressive therapy or chemotherapy. In this PBPM strategy, pharmacists added laboratory test orders for patients who require regular HBV-DNA quantification (HBV-PBPM). Second, we devised PBPM for measurement of the urine protein\/creatinine ratio (UPC) in patients receiving anti-vascular endothelial growth factor therapy. Finally, we introduced PBPM for measurement of serum magnesium in patients receiving anti-epidermal growth factor receptor antibody therapy (Mg-PBPM). In this study, we evaluated the usefulness of these three PBPM strategies in outpatients receiving chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included patients treated in the outpatient chemotherapy unit between July 2021 and February 2023. Rates of compliance with laboratory tests in the 6\u2009months before and after introduction of PBPM were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compliance with HBV-DNA quantification improved significantly from 66.3% before PBPM to 86.7% after implementation of PBPM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). The median duration of noncompliance was significantly shorter after initiation of PBPM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021). Compliance with measurement of UPC was already greater than 95% before PBPM and showed no change after implementation (98.7% pre-PBPM vs 99.3% post-PBPM). Compliance with measurement of serum magnesium improved from 95.8% pre-PBPM to 99.2% after starting PBPM, but the improvement was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Introduction of PBPM improves compliance with the laboratory tests required in cancer patients during chemotherapy and enables safer delivery of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-025-00504-8","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:40:13Z","timestamp":1762958413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Usefulness of protocol-based pharmacotherapy management by pharmacists in cancer patients: a retrospective observational study"],"prefix":"10.1186","volume":"11","author":[{"given":"Satomi","family":"Sumikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"504_CR1","unstructured":"Ministry of Health. Labour and welfare. Promotion of team medical care through collaboration with medical staffs. 2010. Available from: https:\/\/www.mhlw.go.jp\/shingi\/2010\/05\/dl\/s0512-6h.pdf."},{"key":"504_CR2","unstructured":"Japanese Society of Hospital Pharmacists. How to facilitate protocol-based pharmacotherapy management (PBPM) and specific practical examples (Ver.1.0). 2016. Available from: https:\/\/www.jshp.or.jp\/activity\/guideline\/20160331-1.pdf."},{"key":"504_CR3","unstructured":"Japanese society of pharmaceutical health care and sciences. Protocol-based pharmacotherapy management (PBPM) implementation manual. 2016. Available from: https:\/\/www.jsphcs.jp\/wp-content\/uploads\/2024\/10\/20160613-1.pdf."},{"key":"504_CR4","unstructured":"The Japan Society of Hepatology. Hepatitis B Treatment Guidelines. 2022. Available from: https:\/\/www.jsh.or.jp\/lib\/files\/medical\/guidelines\/jsh_guidlines\/B_v4.pdf."},{"key":"504_CR5","unstructured":"Akira T, Ryoo T, Yasuhiro S, Seiichi M, Yuji W, Tomoyuki O, et al. Evaluation of the implementation of HBV-related marker testing during cancer chemotherapy and the effectiveness of medical safety measures. J Educ Chang Jpn Soc Of Pharm Oncol. 2017;6:16\u201323. Available from: https:\/\/jaspo-oncology.org\/file\/224#page=18."},{"key":"504_CR6","doi-asserted-by":"crossref","unstructured":"Chieko S, Masaaki I, Takao O, Naoyuki U. Construction of protocol-based pharmacotherapy management (PBPM) using an electronic medical record interlocking support system to prevent hepatitis B virus reactivation induced by cancer chemotherapy. Jpn J Pharm Health Care Sci. 2022;48(1):9\u201319. Available from: https:\/\/www.jstage.jst.go.jp\/article\/jjphcs\/48\/1\/48_9\/_pdf\/-char\/ja","DOI":"10.5649\/jjphcs.48.9"},{"key":"504_CR7","doi-asserted-by":"crossref","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u201358. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3590441\/","DOI":"10.1038\/bmt.2012.244"},{"key":"504_CR8","doi-asserted-by":"crossref","unstructured":"Sato M, Fujita S, Kimura M, Takeuchi K, Hamahata Y, Matsuda Y. Designing effective protocol-based pharmacotherapy management: assessment of the development processes and outcomes in inflammatory bowel disease care prescription management. Pharm (basel). 2025;13(1). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11860031\/","DOI":"10.3390\/pharmacy13010017"},{"key":"504_CR9","doi-asserted-by":"crossref","unstructured":"Daisuke M, Hiroki T, Kensaku Y, Toru M, Daiki Y, Yukiko A, et al. Pharmacist orderings for blood and urine tests related to pharmaceuticals -practice of protocol-based pharmacotherapy management (PBPM)-. Jpn J Pharm Health Care Sci. 2021;47(7):345\u201357. Available from: https:\/\/www.jstage.jst.go.jp\/article\/jjphcs\/47\/7\/47_345\/_pdf\/-char\/ja","DOI":"10.5649\/jjphcs.47.345"},{"key":"504_CR10","unstructured":"Keiko F, Hideki K, Akane N, Masahiro O, Eguchi Y, et al. The department of pharmacy at Fukuoka University Hospital\u2019s role in preventing hepatitis B virus reactivation in patients taking oral anticancer drugs. Gan To Kagaku Ryoho. 2023;50(8):885\u201389."},{"key":"504_CR11","unstructured":"Hiroyuki W, Ikuko H, Yuka N, Noriyuki H, Tatsuichi A, Takashi Y. Evaluation of effectiveness and implementation of protocol-based pharmacotherapy management for prevention of hepatitis B virus reactivation induced cancer chemotherapy. J Educ Chang Jpn Soc of Pharm Oncol. 2016;5:13\u201318. Available from: https:\/\/jaspo-oncology.org\/file\/225#page=15."},{"key":"504_CR12","doi-asserted-by":"crossref","unstructured":"McBane SE, Dopp AL, Abe A, Benavides S, Chester EA, Dixon DL, et al. Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy. 2015;35(4):e39\u201350. Available from: https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/phar.1563","DOI":"10.1002\/phar.1563"},{"key":"504_CR13","doi-asserted-by":"publisher","unstructured":"Mishra P, Thomas J. Survey of collaborative drug therapy management in U.S. hospitals. Am J Health Syst Pharm. 2017;74(21):1791\u2013905. Available from: https:\/\/doi.org\/10.2146\/ajhp151058","DOI":"10.2146\/ajhp151058"},{"key":"504_CR14","doi-asserted-by":"crossref","unstructured":"Ikesue H, Kusuda K, Satsuma Y, Nishiwaki F, Miura R, Masuda Y, et al. Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer. J Clin Pharm Ther. 2020;45(6):1288\u201394. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7687122\/pdf\/JCPT-45-1288.pdf","DOI":"10.1111\/jcpt.13207"},{"key":"504_CR15","doi-asserted-by":"crossref","unstructured":"Nakamura N, Shiraiwa H, Haruna Y, Ichijima T, Takeda T, Hasegawa K, et al. Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand-foot syndrome in cancer patients: a retrospective study. J Pharm Health Care Sci. 2021;7(1):8. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7919314\/pdf\/40780_2021_Article_191.pdf doi: https:\/\/doi.org\/10.1186\/s40780-021-00191-1.","DOI":"10.1186\/s40780-021-00191-1"},{"key":"504_CR16","unstructured":"Yanagawa T, Kataoka K, Yamashita N, Yanai M, Tanaka K, Bando J, et al. Effects of introducing PBPM for outpatient cancer drug therapy and its impact on Physician workload. Gan To Kagaku Ryoho. 2024;51(7):747\u201351. Available from: https:\/\/www.pieronline.jp\/content\/article\/0385-0684\/51070\/747."},{"key":"504_CR17","doi-asserted-by":"crossref","unstructured":"Asai Y, Nakano Y, Yanagawa T, Takahashi M, Iwamoto T. Impact of a collaborative pharmacist-cardiovascular Surgeon protocol for high risk of postoperative delirium on benzodiazepine prescription trends in hospitalized patients. Biol Pharm Bull. 2025;48(2):177\u201383. Available from: https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/2\/48_b24-00708\/_pdf\/-char\/en.","DOI":"10.1248\/bpb.b24-00708"},{"key":"504_CR18","doi-asserted-by":"crossref","unstructured":"Asai Y, Yanagawa T, Takahashi M. Effect of pharmacist-led intervention protocol on preventing postoperative delirium after elective cardiovascular surgery. PLoS One. 2023;18(10):e0292786. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10569577\/pdf\/pone.0292786.pdf","DOI":"10.1371\/journal.pone.0292786"},{"key":"504_CR19","doi-asserted-by":"crossref","unstructured":"Katada Y, Nakagawa S, Minakata K, Odaka M, Taue H, Sato Y, et al. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery. J Clin Pharm Ther. 2017;42(5):591\u201397. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/jcpt.12560","DOI":"10.1111\/jcpt.12560"},{"key":"504_CR20","doi-asserted-by":"crossref","unstructured":"Urano K, Ishibashi M, Matsumoto T, Ohishi K, Muraki Y, Iwamoto T, et al. Impact of physician-pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study. J Pharm Health Care Sci. 2020;6:9. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7193403\/pdf\/40780_2020_Article_165.pdf","DOI":"10.1186\/s40780-020-00165-9"},{"key":"504_CR21","unstructured":"Komuro M, Toda Y, Ishikawa S, Hyakutake H, Watanabe T, Shimanuki Y, et al. Operational construction and effectiveness verification of an HBV reactivation management protocol for cancer chemotherapy patients based on medical information system safety management. Gan To Kagaku Ryoho. 2025;52(6):457\u201361. Available from: https:\/\/www.pieronline.jp\/content\/article\/0385-0684\/52060\/457."},{"key":"504_CR22","unstructured":"Minori I, Yasuhiko S, Keiji S, Shinichi K, Kouichi H. Approach for appropriate use of urinary protein related anti-VEGF antibody by introducing the PBPM. J Jpn Soc Hosp Pharm. 2017;53(6):703\u201307. Available from: https:\/\/mol.medicalonline.jp\/archive\/search?jo=dg4hppha%26vo=53%26issue=6"},{"key":"504_CR23","doi-asserted-by":"crossref","unstructured":"Alhossan A, Alazba A. Barriers interfering with establishment of collaborative drug therapy management (CDTM) agreements between clinical pharmacists and physicians. Saudi Pharm J. 2019;27(5):713\u201316. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6598211\/pdf\/main.pdf","DOI":"10.1016\/j.jsps.2019.04.006"},{"key":"504_CR24","doi-asserted-by":"crossref","unstructured":"Thomas J, Bharmal M, Lin SW, Punekar Y. Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health Syst Pharm. 2006;63(24):2489\u201399. Available from: https:\/\/academic.oup.com\/ajhp\/article-abstract\/63\/24\/2489\/5134611?redirectedFrom=fulltext%26login=true","DOI":"10.2146\/ajhp050205"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00504-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00504-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00504-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:40:16Z","timestamp":1762958416000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-025-00504-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00504-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7408890\/v1","asserted-by":"object"}]},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects (2015) published by the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare. The study was approved by the Ethics Committee of Ehime University Hospital (approval number 2506003). Informed consent was obtained via the opt-out route on the hospital\u2019s website.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}